AQEMIA
Paris, France· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
AQEMIA is a Paris-based biotechnology company founded in 2019 that is reinventing drug discovery by combining generative AI with proprietary, fast physics-based algorithms. Its platform, QEMI, predicts drug-target interactions from first principles, eliminating the need for experimental training data to design novel molecules. The company is advancing a pipeline focused on oncology and other areas of high unmet medical need.
AI / Machine Learning